Alaska Department of Commerce, Community & Economic Development
06/05/2026 | Press release | Distributed by Public on 06/05/2026 11:15
NOTICE OF ADOPTED AND FILED REGULATIONS OF THE ALASKA STATE MEDICAL BOARD On February 26, 2026, the State Medical Board adopted regulations in Title 12, Chapter 40 of the[...]
NOTICE OF ADOPTED AND FILED REGULATIONS OF THE ALASKA STATE MEDICAL BOARD
On February 26, 2026, the State Medical Board adopted regulations in Title 12, Chapter 40 of the Alaska Administrative Code. The regulations concern standards of practice for the use of buprenorphine to treat opioid use disorder via telemedicine.
The regulations were reviewed and approved by the Department of Law, signed and filed by the Office of the Lieutenant Governor on June 4, 2026, and are effective on July 4, 2026. Attached is a copy of the filed regulations.
The regulation changes will first appear in Register 259, October 2026, of the Alaska Administrative Code.
Alaska Department of Commerce, Community & Economic Development published this content on June 05, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 05, 2026 at 17:15 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]